Colorectal cancer is the third leading cause of cancer-related death, and its incidence is rising in the younger patient population. In the past decade, research has unveiled several processes (underlying tumorigenesis, many of which involve interactions between tumor cells and the surrounding tissue or tumor microenvironment (TME). Interactions between components of the TME are mediated at a sub-microscopic level. However, the endpoint of those interactions results in morphologic changes which can be readily assessed at microscopic examination of biopsy and resection specimens. Among these morphologic changes, alteration to the tumor stroma is a new, important determinant of colorectal cancer progression. Different methodologies to estimate the proportion of tumor stroma relative to tumor cells, or tumor stroma ratio (TSR), have been developed. Subsequent validation has supported the prognostic value, reproducibility and feasibility of TSR in various subgroups of colorectal cancer. In this manuscript, we review the literature surrounding TME in colorectal cancer, with a focus on tumor stroma ratio.
Nodular histiocytic/mesothelial hyperplasia (NHMH) is a benign entity that can simulate malignancies histologically. NHMH was initially described in 13 hernia sacs in 1975. Since then, several cases and case series of NHMH have been reported in the literature with variable nomenclatures. It is always an incidental finding seen in a wide range of patient populations with no predilection for gender, age or race. It is most commonly found on mesothelium-lined surfaces such as peritoneum but can also be seen at other sites. It is hypothesized that NHMH occurs due to irritation of mesothelial surfaces and interaction of adhesion molecules. The histologic mimicry by NHMH of malignant processes can pose a diagnostic challenge. This review aims to highlight clinical and pathological aspects of NHMH and to cover common differential diagnoses with special attention to those pertaining to gastrointestinal tract pathology.